These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375 [TBL] [Abstract][Full Text] [Related]
4. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
6. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers. Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945 [TBL] [Abstract][Full Text] [Related]
7. The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure. Markus H; Cowley AJ Eur J Clin Pharmacol; 1991; 40(6):535-8. PubMed ID: 1884731 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. Dakak N; Makhoul N; Merdler A; Yechiely H; Kahana L; Halon DA; Schneeweiss A; Lewis BS Eur Heart J; 1993 Jun; 14(6):836-44. PubMed ID: 8325314 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study. Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231 [TBL] [Abstract][Full Text] [Related]
10. Chronic alpha-1-adrenergic blockade increases sympathoneural but not adrenomedullary activity in patients with essential hypertension. Jacobs MC; Lenders JW; Willemsen JJ; Thien T J Hypertens; 1995 Dec; 13(12 Pt 2):1837-41. PubMed ID: 8903663 [TBL] [Abstract][Full Text] [Related]
11. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug. Rau R; Hind ID; Wynne RD; White SA Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694 [TBL] [Abstract][Full Text] [Related]
12. A non-invasive evaluation of flosequinan on haemodynamics and exercise capacity in chronic congestive heart failure. Motro M; Freimark D; Feinberg MS; Wynne RD; King C; Schneeweiss A Int J Clin Pharmacol Res; 1993; 13(3):143-9. PubMed ID: 8225697 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension]. Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888 [TBL] [Abstract][Full Text] [Related]
14. Long-term vasodilator treatment with flosequinan does not lead to hemodynamic tolerance or neurohormonal activation in severe heart failure. Bartels GL; Remme WJ; Look MP; Kruijssen DA J Card Fail; 1995 Mar; 1(2):117-25. PubMed ID: 9420641 [TBL] [Abstract][Full Text] [Related]
15. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age]. González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy. Ibrahim MM; el-Boghdadly B; Zaghloul SS J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565 [TBL] [Abstract][Full Text] [Related]
17. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674 [TBL] [Abstract][Full Text] [Related]
18. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A; Mahgoub M; Hall M; Feely J Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [TBL] [Abstract][Full Text] [Related]
19. The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers. Cowley AJ; Wynne RD; Hampton JR J Hypertens Suppl; 1984 Dec; 2(3):S547-9. PubMed ID: 6599715 [TBL] [Abstract][Full Text] [Related]
20. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia. Christensen M; Ibsen H; Worck R Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]